INDV Indivior Plc
Price (delayed)
$9.59
Market cap
$1.28B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.03
Enterprise value
$1.26B
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline
Highlights
INDV's revenue is up by 14% year-on-year and by 2% since the previous quarter
Indivior's gross profit has increased by 10% YoY but it has decreased by 2.1% QoQ
The EPS has plunged by 145% YoY
The net income has dropped by 139% year-on-year
Key stats
What are the main financial stats of INDV
Market
Valuations
Earnings
Shares outstanding
133.98M
Market cap
$1.28B
Enterprise value
$1.26B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
Revenue
$1.15B
EBIT
-$154M
EBITDA
-$126M
Free cash flow
-$345M
Per share
Balance sheet
Liquidity
EPS
-$1.03
Free cash flow per share
-$2.54
Book value per share
-$0.89
Revenue per share
$8.44
TBVPS
$9.69
Total assets
$1.54B
Total liabilities
$1.66B
Debt
$281M
Equity
-$121M
Working capital
-$148M
Debt to equity
-2.32
Current ratio
0.85
Quick ratio
0.63
Net debt/EBITDA
0.17
Margins
Efficiency
Dividend
EBITDA margin
-11%
Gross margin
79.4%
Net margin
-12.3%
Operating margin
-16.5%
Return on assets
-8.3%
Return on equity
N/A
Return on invested capital
-55.3%
Return on capital employed
-29.4%
Return on sales
-13.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INDV stock price
How has the Indivior stock price performed over time
Intraday
-3.13%
1 week
-4.29%
1 month
-24.13%
1 year
-56.61%
YTD
-37.2%
QTD
-40.51%
Financial performance
How have Indivior's revenue and profit performed over time
Revenue
$1.15B
Gross profit
$911M
Operating income
-$189M
Net income
-$141M
Gross margin
79.4%
Net margin
-12.3%
The net income has dropped by 139% year-on-year
The operating income has dropped by 125% year-on-year
Indivior's net margin has plunged by 108% YoY
INDV's operating margin has dropped by 96% year-on-year
Growth
What is Indivior's growth rate over time
Valuation
What is Indivior stock price valuation
P/E
N/A
P/B
N/A
P/S
1.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
The EPS has plunged by 145% YoY
The stock's price to sales (P/S) is 51% less than its last 4 quarters average of 2.4
INDV's revenue is up by 14% year-on-year and by 2% since the previous quarter
Efficiency
How efficient is Indivior business performance
The ROS has plunged by 198% YoY
Indivior's ROA has plunged by 144% YoY
Dividends
What is INDV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INDV.
Financial health
How did Indivior financials performed over time
Indivior's total assets is 7% lower than its total liabilities
The quick ratio has contracted by 33% YoY and by 6% from the previous quarter
The current ratio has contracted by 25% YoY and by 8% from the previous quarter
The debt to equity has dropped by 197% year-on-year and by 108% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.